Can leptin-specific epigenetic modulation of preterm cord blood predispose obesity?

Navya Sree Boga,Amit K Banerjee,Saikanth Varma,Archana Molangiri,Syeda Farhana,Santosh Kumar Banjara,Nitasha Bagga,Asim K Duttaroy,Sanjay Basak
DOI: https://doi.org/10.1101/2024.12.16.24319077
2024-12-16
Abstract:Objective: This retrospective cohort investigated the role of leptin's promoter methylation and microRNA targeting profile in developing adiposity and inflammation in neonates, using umbilical cord blood from preterm (n=67) and term (n=71) mothers. Methods: Global DNA methylation and leptin promoter methylation were performed. ELISA determined leptin and IGF1 levels. Real-time PCR measured mRNA levels. MicroRNA target prediction on the human leptin gene (LEP) was done in silico using network analysis. Results: Preterm cord blood significantly reduced genome-wide (p<0.001) and LEP promoter methylation (p=0.001), increased LEP & LEPR expression (p=0.04), and circulatory leptin (p=0.41). Neonatal birth weight positively correlated with leptin and IGF1 levels in preterm (r=0.47, p=0.04) but not in the term. IL6 expression showed a positive correlation with circulatory leptin (r= 0.687, p=0.008), LEP (r= 0.763, p=0.009), and an inverse association with LEP promoter methylation (r= -0.636, p=0.04) in preterm. The obtained LEP targeting miRNAs showed their affinities for critical genes associated with body fat distribution, fat cell differentiation, and energy regulation, implicating a close association in the LEP-miRNA-obesity axis. Conclusions: The strong correlation between LEP methylation and pro-inflammatory cytokine influences each other in developing chronic inflammation in preterm neonates, which might predispose them to obesity in later life.
What problem does this paper attempt to address?